Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002037320 | SCV002115423 | likely benign | not provided | 2023-12-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003164003 | SCV003884026 | likely benign | Inborn genetic diseases | 2023-01-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004738397 | SCV005361160 | uncertain significance | DEAF1-related disorder | 2024-05-22 | no assertion criteria provided | clinical testing | The DEAF1 c.935C>G variant is predicted to result in the amino acid substitution p.Thr312Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.036% of alleles in individuals of African descent in gnomAD. This variant is interpreted as likely benign in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/1345478/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |